Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:957-962
doi: 10.1161/hc3401.093156
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duytschaever, M.
Right arrow Articles by Allessie, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duytschaever, M.
Right arrow Articles by Allessie, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation
Related Collections
Right arrow Electrophysiology
Right arrow Arrythmias-basic studies

(Circulation. 2001;104:957.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Methods for Determining the Refractory Period and Excitable Gap During Persistent Atrial Fibrillation in the Goat

Mattias Duytschaever, MD; Frans Mast, PhD; Matthijs Killian, PhD; Yuri Blaauw, MD; Maurits Wijffels, MD, PhD; Maurits Allessie, MD, PhD

From the Department of Physiology, Maastricht University, Maastricht, the Netherlands.

Correspondence to Prof M.A. Allessie, Department of Physiology, Maastricht University, PO Box 616, 6200 MD Maastricht, the Netherlands.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— Recently, the temporal excitable gap during atrial fibrillation (AF) has been identified as a vulnerable parameter for cardioversion of AF. In this study, we evaluated 5 methods to measure the refractory period (RPAF) and the excitable period (EPAF) during persistent AF.

Methods and Results— In 11 goats instrumented with 83 epicardial atrial electrodes, persistent AF (43±34 days) was induced with a median AF cycle length (CL) of 98±14 ms. To measure RPAF, premature stimuli were applied to the center of the electrode array on the right or left atrium. The RPAF measured by mapping of premature stimuli was 70±12 ms ("gold standard"). The RPAF determined during entrainment of AF was 77±17 ms (R2=0.88, P<0.01). Statistical analysis of the effects of synchronized stimuli (each coupling interval x100) on the AFCL histogram yielded an RPAF of 70±13 ms (R2=0.94, P<0.01). A further simplification was to apply slow fixed-rate pacing (1 Hz) during AF. For each stimulus (n=250 to 500), the paced AFCL was plotted against its coupling interval, and capture was determined by statistical shortening of the AFCL (RPAF 71±17 ms, R2=0.84, P<0.01). The 5th percentile of the AFCL histogram as an index of RPAF was 77±12 ms (R2=0.90, P<0.01).

Conclusions— During persistent AF with an AFCL of 98±14 ms, the RPAF determined by mapping of synchronized premature stimuli (gold standard) was 70±12 ms, with an excitable period of 28±8 ms. Although the indirect methods to measure RPAF all correlated well with the gold standard, slow fixed-rate pacing seems to be the most attractive technique because of the ease of acquiring the data and the clear graphic result.


Key Words: fibrillation • electrophysiology • excitation


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
It was recently suggested that the temporal excitable gap during atrial fibrillation (AF) is a critical determinant for perpetuation and termination of AF.1,2 In the presence of a short excitable gap, fibrillation waves are more likely to die out by encountering refractory tissue. Conversely, a short excitable gap may also promote the formation of new wavelets because of an increase in the likelihood of intra-atrial conduction block. Thus far, determination of the excitable gap during AF has been limited to the recording of monophasic action potentials.3,4 Recently, the refractory period during persistent AF (RPAF) has been measured directly by programmed electrical stimulation.2,5 Cardioversion by class I drugs was found to be associated with a 2- to 3-fold widening of the temporal excitable gap.2

The aim of the present study was to develop clinical tools for the measurement of the RPAF and temporal excitable gap during persistent AF. Five methods were evaluated in a goat model of persistent AF using mapping as "gold standard."


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The goat model of AF was described previously.6 In 11 goats (51±8 kg), 2 plaques (3.5x2.5 cm, 30 electrodes, distance 4 mm) were sutured to the free wall of the right atrium (RA) and left atrium (LA). One strip (6x1 cm, 23 electrodes, distance 6 to 10 mm) was pulled along Bachmann’s bundle and sutured to both atrial appendages. The leads were tunneled subcutaneously to the neck and exteriorized by three 30-pin connectors. A subcutaneous silver plate served as indifferent electrode. After the goats had recovered from surgery, persistent AF was produced by a fibrillation pacemaker.6 After amplification (x300) and filtering (1 to 500 Hz), all unipolar atrial electrograms were stored on tape. Local activation times were determined automatically by a custom-made algorithm detecting the maximal negative slope of the fibrillation electrograms. The goats were studied after 43±34 days of AF at a median AF cycle length (CL) of 98±14 ms. A central pair of electrodes on the RA (n=7) or LA (n=4) was used for stimulation. Biphasic stimuli of 2 ms were generated by a constant-current stimulator equipped with an amplifier recording a bipolar electrogram from the pacing electrodes (Medtronic SP3111). The minimal current required for regional entrainment of AF was taken as the threshold for stimulation.7

Methods to Measure RPAF
Figure 1 illustrates the 5 methods to measure RPAF. Mapping was used as the gold standard. Single premature stimuli of 4x threshold were synchronized to the fibrillation waves at the pacing site. Capture was verified by activation maps around the pacing site. In case of capture, the atrium was activated in a radial fashion from the site of pacing.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 1. Five methods to determine RPAF. (1) Mapping of premature stimuli during AF, (2) premature stimuli (S1-S2) during entrainment of AF, (3) statistical analysis of effect of synchronized premature stimuli (n=100), (4) fixed-rate pacing (1 Hz) during AF resulting in randomly applied premature stimuli, and (5) 5th percentile of AFCL.

A second method to measure RPAF is to apply premature stimuli during regional entrainment of AF with an interval equal to the median AFCL. The S1-S2 interval was changed in steps of 2 ms. Capture was determined by the latency and morphology of an electrogram recorded 4 mm from the pacing site. In case of capture, the premature electrogram showed a morphology and latency similar to that during entrainment. The longest S1-S2 interval that failed to capture the atria was taken as the RP during entrainment of AF.

A third method to measure RPAF is to determine the statistical effect of synchronized premature stimuli on the AFCL histogram. Each coupling interval was repeated 100 times. The shortest coupling interval resulting in a statistically significant difference in AFCL histogram was taken as the RPAF (Wilcoxon 2-sample test).

A fourth method to determine RPAF is to pace the fibrillating atria at a slow fixed rate (1 Hz). Because of the irregularity of AF, slow pacing actually results in a series of randomly applied premature stimuli. A computer algorithm was used to determine the coupling interval at the pacing site (AF-S) and the associated AFCL at a neighboring electrogram. At least 250 consecutive stimuli were analyzed. The shortest coupling interval (classes of 5 ms) resulting in a significant shortening of AFCL (Kolmogorov-Smirnov 1-sample test) was defined as the RPAF. Because this method was developed during evaluation of the other techniques, it was applied only in the last 6 of 11 goats.

A fifth method to estimate RPAF is to determine the 5th percentile of the AFCL histogram, constructed from >=100 consecutive AF cycles from a unipolar RA or LA electrogram.

Excitable Gap During AF
The term "excitable gap" refers to both the excitable tissue between fibrillation waves (spatial excitable gap) and the time window of excitability during the AF interval (temporal excitable gap). We used the term excitable period (EPAF) to indicate the temporal excitable gap. With all 5 methods, EPAF can be calculated as the difference between the median AFCL and RPAF. During fixed-rate pacing, EPAF could be directly measured from the histogram of the interval between the stimulus and the first response (S-AF). Whereas during subthreshold pacing, the S-AF intervals were equally distributed, pacing at 4x threshold caused a gap in the S-AF histogram. The longest S-AF interval occurring less frequently than expected (95% CI) was taken as the EPAF.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Mapping of the Refractory Period During AF
Figure 2 shows an example of the RPAF determined by mapping. In the upper panel, a stimulus was applied 70 ms after the pacing site was activated. The activation map shows that the stimulus did not capture the atrium. A stimulus with a slightly longer interval of 75 ms (lower panel) resulted in capture, as evidenced by radial spread of activation from the pacing site. When stimuli with the same coupling interval were repeated 20x, however, sometimes capture occurred and sometimes not. In Figure 3, we plotted the percentage of capture at different coupling intervals. At short coupling intervals (<65 ms), the atrium was never captured. Prolonging the interval from 65 to 90 ms resulted in a progressive increase in the probability of capture. A coupling interval >90 ms resulted in 100% capture. The S-shaped curve shows that the RPAF is not a deterministic but a probabilistic variable. We arbitrarily defined the RPAF as the shortest coupling interval that captured the atrium >=20% of the time. This value represents the shortest of a wider range of refractory periods during AF. In all goats, the RPAF measured in this way was 70±12 ms. The temporal variation in RPAF (5% to 95% capture) was 19±4 ms.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 2. Representative example of capture by a single synchronized stimulus. Electrograms were recorded at pacing site (bipolar) and a neighboring electrode (unipolar).



View larger version (35K):
[in this window]
[in a new window]
 
Figure 3. Probability of capture of AF by premature stimuli. S-shaped curve shows temporal variation in RPAF.

Refractory Period During Entrainment of AF
Figure 4 shows an example of the RP during entrainment of AF. Entrainment was performed at the LA with an S1-S1 interval of 110 ms (median AFCL 113 ms). The unipolar electrogram recorded next to the pacing site shows 8 entrained beats followed by a single premature stimulus (S2). During entrainment, the activation maps revealed radial spread of activation. An S2 stimulus of 90 ms did not capture the atrium, whereas an S2 stimulus with a coupling interval of 92 ms did capture the atrium (radial spread). For determination of the RPAF, capture was verified by the morphology of the unipolar electrogram next to the pacing site. In case of no capture, the electrogram showed a clear R wave and a variable time interval between the stimulus and the next activation. In case of capture by the premature stimulus, the latency and electrogram morphology were similar to those during entrainment of AF (no R wave). The RP during entrainment, defined as the longest S1-S2 interval that did not capture the atrium, was 77±17 ms (6 goats).



View larger version (32K):
[in this window]
[in a new window]
 
Figure 4. Measurement of RP during entrainment of AF. Electrogram was recorded 4 mm from pacing site. Premature stimulus with coupling interval of 90 ms did not capture atrium, whereas an S1-S2 interval of 92 ms captured atria (no R wave; short latency).

Measurement of the RPAF by Synchronized Stimuli
The response to synchronized stimuli was determined statistically by applying a premature stimulus 100 times. For each coupling interval, a histogram of the paced AFCL was reconstructed from a neighboring electrogram. In Figure 5, an example is given of a premature stimulus with a coupling interval of 50 ms. The control AFCL histogram (sampled 1 second before each premature stimulus) shows a normal distribution with a median AFCL of 80 ms. In contrast, the paced AFCL histogram showed a bimodal distribution. Because of capture, 39% of the AF cycles were now <60 ms. The Wilcoxon 2-sample test revealed a significant difference between the 2 histograms (P<0.05). Premature stimuli with a coupling interval of <50 ms did not result in statistically different AFCL histograms. In 11 goats, the RPAF measured by the shortest coupling interval yielding a statistically different AFCL was 70±13 ms. This value represents the shortest of a range of refractory periods during AF.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 5. Determination of RPAF by statistical analysis of paced AFCL histogram close to pacing site. During administration of premature stimuli with a coupling interval of 50 ms (n=100), histogram showed a shift to left due to capture of part of stimuli.

Measurement of the RPAF by Fixed-Rate Pacing
An alternative way to determine RPAF is to stimulate the fibrillating atria at a slow fixed rate of 1 Hz, resulting in a series of randomly applied premature stimuli. In Figure 6, the AFCL at an electrode close to the pacing site is plotted for all coupling intervals during 4 minutes of fixed-rate pacing (n=240). Two populations of data points can be clearly distinguished. At shorter coupling intervals, AFCL shows the normal variation (median 88 ms). At longer coupling intervals, the normal variation in AFCL was lost, and because of capture, the paced AFCL was now determined by the coupling interval of the stimulus. At intermediate coupling intervals (48 to 69 ms), only part of the stimuli captured the atrium, illustrating the temporal variation in RPAF (shaded column). In all goats, the range of temporal variation of the RPAF was 24±7 ms. The shortest coupling interval producing a significant shortening of AFCL, as determined by the Kolmogorov-Smirnov test, was 71±17 ms. This method was applied only in the last 6 of 11 goats, because it was developed during evaluation of the other techniques in the first 5 goats.



View larger version (36K):
[in this window]
[in a new window]
 
Figure 6. Determination of RPAF by slow fixed-rate pacing (1 Hz). During 250 consecutive stimuli, paced AFCL is plotted against its coupling interval. Shaded column indicates range of refractory periods during AF.

With fixed-rate pacing, EPAF can be directly visualized (Figure 7). During 16 to 17 minutes of 1 Hz pacing, all poststimulus intervals (n=1000) were plotted in a histogram. During subthreshold pacing, the S-AF intervals were equally distributed, with a mean incidence of 10.7±2.9 (95% CI between 4.9 and 16.5). When stimulus strength was set at 4x threshold, the S-AF intervals were no longer equally distributed. Now, a high incidence (n=368) of short S-AF intervals was observed, representing the latency between stimulus and response during capture. At the same time, the incidence of S-AF intervals between 5 and 30 ms markedly decreased. These intervals disappeared because they were shortened by capture of the premature stimuli. The distribution of S-AF intervals >35 ms did not change during pacing. The upper limit of the excitable period was determined by the longest S-AF interval that occurred less frequently than the 95% CI. In 6 goats, EPAF measured in this way was 27±4 ms. This value represents the longest of a range of excitable periods during AF. Because of variation in AFCL and RPAF, during many cycles EPAF will actually be shorter. This is illustrated in Figure 7 by the atrial responses that still occurred during the measured excitable period.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 7. Determination of excitable period during AF by fixed-rate pacing. Horizontal dotted line represents 95% confidence limit of incidence of S-AF intervals during subthreshold pacing.

p5 AFCL Value as an Index of the RPAF
In 11 goats, the median AFCL measured at the RA or LA was 98±14 ms. The 95th and 5th percentiles of the AFCL were 120±16 and 77±12 ms. The 5th percentile (p5) value was used as an index of RPAF. This is based on the assumption that the shortest AF cycle lengths have no or only a very short excitable period.

Comparison of the Different Measurements of the RPAF
In Table 1, the values of RPAF as obtained by the 5 methods are listed for all goats. The RPAF measured by mapping is considered the gold standard. All methods yielded an RPAF between 70 and 80 ms. During entrainment, the RP was 4±5 ms longer than the RPAF determined by mapping (77±17 versus 73±15 ms, P=0.12). The correlation between the values obtained by entrainment and mapping was 0.88 (P<0.01). The RPAF determined by synchronized stimuli yielded the same values as obtained by mapping (70±13 versus 70±12; R2=0.94; P<0.01). The RPAF measured by fixed-rate pacing also gave a similar result (71±17 versus 73±15 ms; R2=0.84; P<0.01). The 5th percentile of the AFCL histogram was 7±4 ms longer than RPAF measured by mapping (77±12 versus 70±12 ms, P<0.05), with a correlation coefficient of 0.90 (P<0.01). Although the study was not designed to compare measurements in RA and LA, AFCL and RPAF were consistently longer and showed more variation in the RA (P=0.33 to 0.47).


View this table:
[in this window]
[in a new window]
 
Table 1. RPAF Values Obtained by Different Methods


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Refractory Period During Atrial Fibrillation
The present study shows that the refractory period during AF exhibits a considerable temporal variation. Measurement of RPAF by mapping or fixed-rate pacing revealed a time window of 20 to 25 ms during which premature stimuli sometimes captured the atrium and sometimes not (Figures 3 and 6). This probabilistic nature of RPAF is probably a result of beat-to-beat variations in AFCL and direction of propagation. Also, fragmentation of fibrillation waves and electrotonic modulation of the action potential by dissociated neighboring wavelets may cause temporal variation in RPAF.8,9 The RPAF measured by mapping was defined as the coupling interval resulting in >20% capture. The other methods also determined the shortest refractory period during AF. The values obtained by the 5 methods ranged between 70±12 and 77±17 ms (70% to 80% of median AFCL). Although these measurements of the refractory period ignore the existing temporal variation, they may be useful to explore the effects of changes in RPAF on perpetuation and termination of AF. In addition, they might be of value to evaluate the spatial variation in refractory periods during AF. The observed greater variability in AFCL and RPAF in the right atrium may be associated with a more complex geometry, allowing 3D propagation during AF.10

Comparison of Different Techniques to Measure RPAF
The different methods to measure RPAF all have certain advantages and disadvantages (Table 2). Mapping of premature stimuli is the most reliable technique and can be regarded as the gold standard. Because of its complexity and invasive nature, however, it can be used only under exceptional circumstances. Measurement of the refractory period during entrainment of AF has the advantage that it uses the conventional extrastimulus technique (S1-S2) and that it can also be applied during paroxysmal AF. The somewhat longer values obtained during entrainment are probably a result of electrotonic prolongation of the action potential at the pacing site.9 Conversely, entrainment of AF is not always feasible during type III AF.1113 Statistical comparison of the AFCL histogram during synchronized premature stimuli is a highly objective way to determine the RPAF. It is a rather complex technique, however, requiring specific expertise. The easiest way to pace the atria during AF is slow fixed-rate pacing. The required equipment is limited to a standard pacemaker, a multipolar catheter, and software for data analysis. The data acquisition time is {approx}15 minutes, during which no intervention by the electrophysiologist is needed. This method produces a clear graphic output from which both RPAF and EPAF can be directly read out. It was applied only in the last 6 of 11 goats, because the technique was developed in the first 5 goats. Although the p5 AFCL is even more simple, its reliability is questionable. During administration of class I drugs, the RPAF became considerably shorter than the p5 AFCL.2


View this table:
[in this window]
[in a new window]
 
Table 2. Comparison of Different Techniques to Measure the RPAF

Excitable Period During Atrial Fibrillation
In the present study, EPAF, calculated as the difference between AFCL (98±14 ms) and RPAF (70±12 ms), was 28±8 ms. The EPAF measured directly during fixed-rate pacing was 27±4 ms (Figure 7). EPAF, however, must also show a considerable temporal variation. In our experiments, the p5 and p95 AFCL were 77±12 and 120±16 ms. This variation in AFCL (43±8 ms) cannot be completely explained by the variability in RPAF (19±4 ms). This implies that at short AF cycles, the excitable period may become as short as 7 ms, whereas during long cycles, the excitable period might be as long as 50 ms. This beat-to-beat variability in EPAF may play a role in perpetuation of AF.

The excitable period during AF might be explained by the different types of reentry during AF.1 In case an impulse circulates around an anatomic obstacle, EPAF is determined by the difference between the conduction time around the obstacle and the refractory period within the reentrant circuit.14 In case of functional reentry, EPAF is caused by the curvature of the circulating wavefront at pivot points. Because of the high curvature, the excitatory current generated by the turning wavefront may not be enough to make a rapid 180° turn,1517 and the resulting conduction delay creates an excitable period in the returning limb of the turning wavefront.18 In addition, when functional reentrant circuits are drifting through the myocardium, the excitable gap will be shortened or lengthened by the Doppler effect.19,20 In case of random reentry, an excitable period will arise at areas remote from the site of reentry because of the anterograde and retrograde conduction time to the site of reentry.1 Conversely, the excitable period will be shortened by epicardial breakthrough of wave fronts propagating in one of the pectinate muscles.10 The resulting short circuit of epicardial reentry may play an important role in perpetuation of AF, not only because of the 3D nature of the reentrant process but also by narrowing its excitable gap.

We recently suggested that EPAF might be a critical determinant for termination of AF. Cardioversion of persistent AF by class I drugs was associated with a dose-dependent widening of EPAF.2 We speculated that widening of the EPAF decreases the number of head-tail interactions between fibrillation waves, resulting in less dissociation and a higher degree of organization of the multiple wavelets. Cardioversion of AF would occur if multiple wavelets would fuse into a single wave front whose circulating pathway is ultimately interrupted. The possibility cannot be excluded, however, that under other circumstances, cardioversion of AF might be due to closure of the excitable period. Measurement of RPAF and EPAF during pharmacological cardioversion of AF by the methods developed in the present study may further elucidate the significance of the excitable period for termination of AF.

Limitations
In the present study, epicardial mapping was used to determine RPAF. Because no endocardial recordings were made, the 3D structure of the atrial wall, which might play a role in the activation during AF,10 was not taken into account. Also, the study was not designed to determine differences in AFCL, RPAF, and EPAF at different atrial sites. Variation in atrial architecture and underlying geometric discontinuities may cause spatial variability in the RP and EP during AF. Future clinical studies measuring RPAF with the use of a catheter will be needed to elucidate differences between RA and LA. Another limitation is that measurements of RPAF were not compared with monophasic action potential recordings. Therefore, it remains unknown whether the EPAF is due to a diastolic interval between the successive action potentials during fibrillation. Because in the present study, RPAF was measured by chronically implanted epicardial electrodes, clinical application of these methods must await validation by use of multipolar endocardial catheters.


*    Acknowledgments
 
Dr Duytschaever is a recipient of a Research Fellowship from the Scientific Research Fund, Flanders.

Received January 29, 2001; revision received May 1, 2001; accepted May 2, 2001.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Allessie MA, Konings KTS, Kirchof CJHJ, et al. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol. 1996; 77: 10A–23A.[Medline] [Order article via Infotrieve]

2. Wijffels MCEF, Dorland R, Mast F, et al. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: the effects of cibenzoline, hydroquinidine, flecinide, and d-sotalol. Circulation. 2000; 102: 260–267.[Abstract/Free Full Text]

3. Franz MR. The role of monophasic action potential recording in atrial fibrillation.In: Olsson SB, Allessie MA, Campbell RW, eds. Atrial Fibrillation: Mechanisms and Therapeutic Strategies Armonk, NY: Futura Publishing Co Inc; 1994: 109–125.

4. Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Circulation. 1997; 96: 4298–4306.[Abstract/Free Full Text]

5. Shinagawa K, Mitamura H, Takeshita A, et al. Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs: direct assessment of the wavelength and its modulation by a sodium channel blocker pilsicainide. J Am Coll Cardiol. 2000; 35: 246–253.[Abstract/Free Full Text]

6. Wijffels MCEF, Kirchof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995; 92: 1954–1968.[Abstract/Free Full Text]

7. Kirchof CJHJ, Chorro F, Scheffer GJ, et al. Regional entrainment of atrial fibrillation studied by high-resolution mapping in open-chest dogs. Circulation. 1993; 88: 736–749.[Abstract/Free Full Text]

8. Spach MS, Dolber PC, Heidlage JF. Interaction of inhomogeneities of repolarization with anisotropic propagation in dog atria. a mechanism for both preventing and initiating reentry. Circ Res. 1989; 65: 1612–1631.[Abstract/Free Full Text]

9. Davidenko JM, Delmar M, Beaumont J, et al. Electrotonic inhibition and active facilitation of excitability in ventricular muscle. J Cardiovasc Electrophysiol. 1994; 5: 945–960.[Medline] [Order article via Infotrieve]

10. Gray RA, Pertsov AM, Jalife J. Incomplete reentry and epicardial breakthrough patterns during atrial fibrillation in the sheep heart. Circulation. 1996; 94: 2649–2661.[Abstract/Free Full Text]

11. Daoud EG, Pariseau B, Niebauer M, et al. Response to type I atrial fibrillation to atrial pacing in humans. Circulation. 1996; 94: 1036–1040.[Abstract/Free Full Text]

12. Pandozi C, Bianconi L, Villani M, et al. Local capture by atrial pacing in spontaneous chronic atrial fibrillation. Circulation. 1997; 95: 2416–2422.[Abstract/Free Full Text]

13. Capucci A, Ravelli F, Nollo G, et al. Capture window in human atrial fibrillation evidence of an excitable gap. J Cardiovasc Electrophysiol. 1999; 10: 319–327.[Medline] [Order article via Infotrieve]

14. Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabbit atrial muscle as a mechanism of tachycardia, III: the "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res. 1977; 41: 9–18.[Free Full Text]

15. Spach MS, Miller WT, Dolber PC, et al. The functional role of structural complexities in the propagation of depolarization in the atrium of the dog: cardiac conduction disturbances due to discontinuities of effective axial resistivity. Circ Res. 1982; 50: 175–191.[Free Full Text]

16. Fast VG, Kleber AG. Role of wavefront curvature in propagation of cardiac impulse. Cardiovasc Res. 1997; 33: 258–271.[Abstract/Free Full Text]

17. Girouard SD, Pastore JM, Laurita KR, et al. Optical mapping in a new guinea pig model of ventricular tachycardia reveals mechanisms for multiple wavelengths in a single reentrant circuit. Circulation. 1996; 93: 603–113.[Abstract/Free Full Text]

18. Danse P, Garratt C, Mast F, et al. Preferential depression of conduction around a pivot point in rabbit ventricular myocardium by potassium and flecainide. J Cardiovasc Electrophysiol. 2000; 11: 262–273.[Medline] [Order article via Infotrieve]

19. Davidenko JM, Pertsov AV, Salomonsz R, et al. Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature. 1992; 355: 349–351.[Medline] [Order article via Infotrieve]

20. Ikeda T, Uchida T, Hough D, et al. Mechanism of spontaneous termination of functional reentry in isolated canine right atrium: evidence for the presence of an excitable but nonexcited core. Circulation. 1996; 94: 1962–1973.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
H.-R. Neuberger, U. Schotten, Y. Blaauw, D. Vollmann, S. Eijsbouts, A. van Hunnik, and M. Allessie
Chronic Atrial Dilation, Electrical Remodeling, and Atrial Fibrillation in the Goat
J. Am. Coll. Cardiol., February 7, 2006; 47(3): 644 - 653.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
V. Jacquemet, N. Virag, and L. Kappenberger
Wavelength and vulnerability to atrial fibrillation: Insights from a computer model of human atria
Europace, January 1, 2005; 7(s2): S83 - S92.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Blaauw, H. Gogelein, R.G. Tieleman, A. van Hunnik, U. Schotten, and M.A. Allessie
"Early" Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat
Circulation, September 28, 2004; 110(13): 1717 - 1724.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. G. KLEBER and Y. RUDY
Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias
Physiol Rev, April 1, 2004; 84(2): 431 - 488.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Ashihara, T. Namba, T. Ikeda, M. Ito, K. Nakazawa, and N. Trayanova
Mechanisms of Myocardial Capture and Temporal Excitable Gap During Spiral Wave Reentry in a Bidomain Model
Circulation, February 24, 2004; 109(7): 920 - 925.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. G. Akar, T. H. Everett, R. Ho, J. Craft, D. E. Haines, A. P. Somlyo, and A. V. Somlyo
Intracellular Chloride Accumulation and Subcellular Elemental Distribution During Atrial Fibrillation
Circulation, April 8, 2003; 107(13): 1810 - 1815.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Kawase, T. Ikeda, K. Nakazawa, T. Ashihara, T. Namba, T. Kubota, K. Sugi, and H. Hirai
Widening of the Excitable Gap and Enlargement of the Core of Reentry During Atrial Fibrillation With a Pure Sodium Channel Blocker in Canine Atria
Circulation, February 18, 2003; 107(6): 905 - 910.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duytschaever, M.
Right arrow Articles by Allessie, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duytschaever, M.
Right arrow Articles by Allessie, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation
Related Collections
Right arrow Electrophysiology
Right arrow Arrythmias-basic studies